Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation & Amortization (CF): 2016-2024

Historic Depreciation & Amortization (CF) for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $13.6 million.

  • Organogenesis Holdings' Depreciation & Amortization (CF) rose 12.86% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 14.10%. This contributed to the annual value of $13.6 million for FY2024, which is 30.39% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Depreciation & Amortization (CF) of $13.6 million as of FY2024, which was up 30.39% from $10.4 million recorded in FY2023.
  • Organogenesis Holdings' Depreciation & Amortization (CF)'s 5-year high stood at $13.6 million during FY2024, with a 5-year trough of $4.4 million in FY2020.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $10.4 million (2023), whereas its average is $10.0 million.
  • Data for Organogenesis Holdings' Depreciation & Amortization (CF) shows a peak YoY soared of 78.75% (in 2023) over the last 5 years.
  • Over the past 5 years, Organogenesis Holdings' Depreciation & Amortization (CF) (Yearly) stood at $4.4 million in 2020, then soared by 30.26% to $5.8 million in 2021, then rose by 1.11% to $5.8 million in 2022, then spiked by 78.75% to $10.4 million in 2023, then soared by 30.39% to $13.6 million in 2024.